Perforin mutations in patients with FHL2
UPN, mutations . | Mutation type . | Predicted effect . |
---|---|---|
210 | ||
del 50T | Homozygous | L17 FsX |
235 | ||
del 847-852 | Heterozygous | del L283-L284 |
C272T | Heterozygous | A91V |
256 | ||
C272T | Heterozygous | A91V |
G695A | Heterozygous | R232H |
314 | ||
G1122A | Homozygous | W374X |
306 | ||
G1122A | Heterozygous | W374X |
C657A | Heterozygous | Y219X |
UPN, mutations . | Mutation type . | Predicted effect . |
---|---|---|
210 | ||
del 50T | Homozygous | L17 FsX |
235 | ||
del 847-852 | Heterozygous | del L283-L284 |
C272T | Heterozygous | A91V |
256 | ||
C272T | Heterozygous | A91V |
G695A | Heterozygous | R232H |
314 | ||
G1122A | Homozygous | W374X |
306 | ||
G1122A | Heterozygous | W374X |
C657A | Heterozygous | Y219X |
Perforin gene mutations in both alleles are listed in the table, including 5 patients with FHL. Perforin expression was tested by flow cytometry, and was found to be absent in all 5 patients.
UPN indicates unique patient number; X, stop; Fs, frameshift.